Literature DB >> 25727228

Stereotactic radiosurgery and immunotherapy for metastatic spinal melanoma.

James P Caruso1, Or Cohen-Inbar, Mark H Bilsky, Peter C Gerszten, Jason P Sheehan.   

Abstract

The management of metastatic spinal melanoma involves maximizing local control, preventing recurrence, and minimizing treatment-associated toxicity and spinal cord damage. Additionally, therapeutic measures should promote mechanical stability, facilitate rehabilitation, and promote quality of life. These objectives prove difficult to achieve given melanoma's elusive nature, radioresistant and chemoresistant histology, vascular character, and tendency for rapid and early metastasis. Different therapeutic modalities exist for metastatic spinal melanoma treatment, including resection (definitive, debulking, or stabilization procedures), stereotactic radiosurgery, and immunotherapeutic techniques, but no single treatment modality has proven fully effective. The authors present a conceptual overview and critique of these techniques, assessing their effectiveness, separately and combined, in the treatment of metastatic spinal melanoma. They provide an up-to-date guide for multidisciplinary treatment strategies. Protocols that incorporate specific, goal-defined surgery, immunotherapy, and stereotactic radiosurgery would be beneficial in efforts to maximize local control and minimize toxicity.

Entities:  

Keywords:  CTLA-4 = cytotoxic T-lymphocyte antigen–4; IFN = interferon; IL-2 = interleukin-2; LINAC = linear accelerator; MHC = major histocompatibility complex; NK = natural killer; NOMS = Neurological deficits, Oncological features, Mechanical spinal instability, and Systemic disease progression; PD-1 = programmed death–1; PD-L1, -L2 = programmed death–1 ligands 1 and 2; SRS = stereotactic radiosurgery; TIL = tumor-infiltrating lymphocyte; Th1 = helper T cell Type 1; cEBRT = conventional external-beam radiation therapy; immunotherapy; metastatic spinal melanoma; review; separation surgery; stereotactic radiosurgery

Mesh:

Year:  2015        PMID: 25727228     DOI: 10.3171/2014.11.FOCUS14716

Source DB:  PubMed          Journal:  Neurosurg Focus        ISSN: 1092-0684            Impact factor:   4.047


  5 in total

Review 1.  Separation surgery for metastatic epidural spinal cord compression: A qualitative review.

Authors:  Giuseppe Di Perna; Fabio Cofano; Cristina Mantovani; Serena Badellino; Nicola Marengo; Marco Ajello; Ludovico Maria Comite; Giuseppe Palmieri; Fulvio Tartara; Francesco Zenga; Umberto Ricardi; Diego Garbossa
Journal:  J Bone Oncol       Date:  2020-09-26       Impact factor: 4.072

2.  MIR-520f Regulated Itch Expression and Promoted Cell Proliferation in Human Melanoma Cells.

Authors:  Ming-Xia Sun; Qun An; La-Mei Chen; Ling Guo
Journal:  Dose Response       Date:  2020-05-04       Impact factor: 2.658

3.  Abscopal Effect of Frozen Autograft Reconstruction Combined with an Immune Checkpoint Inhibitor Analyzed Using a Metastatic Bone Tumor Model.

Authors:  Noritaka Yonezawa; Hideki Murakami; Satoru Demura; Satoshi Kato; Shinji Miwa; Katsuhito Yoshioka; Kazuya Shinmura; Noriaki Yokogawa; Takaki Shimizu; Norihiro Oku; Ryo Kitagawa; Makoto Handa; Ryohei Annen; Yuki Kurokawa; Kazumi Fushimi; Eishiro Mizukoshi; Hiroyuki Tsuchiya
Journal:  Int J Mol Sci       Date:  2021-02-17       Impact factor: 5.923

4.  Metastatic spine disease in lung cancer patients: national patterns of radiation and surgical care.

Authors:  Patrick D Kelly; Scott L Zuckerman; Khoi D Than; Albert Attia; Jerry J Jaboin
Journal:  J Spine Surg       Date:  2019-09

5.  Predictive Analytics in Spine Oncology Research: First Steps, Limitations, and Future Directions.

Authors:  Elie Massaad; Nida Fatima; Muhamed Hadzipasic; Christopher Alvarez-Breckenridge; Ganesh M Shankar; John H Shin
Journal:  Neurospine       Date:  2019-12-31
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.